Impact of NAD(P)H:Quinone Oxidoreductase-1 on Pigmentation  by Choi, Tae-Young et al.
Impact of NAD(P)H:Quinone Oxidoreductase-1 on
Pigmentation
Tae-Young Choi1, Kyung-Cheol Sohn1, Jin-Hwa Kim2, Seong-Min Kim2, Cheol-Hee Kim3, Jae-Sung Hwang4,
Jeung-Hoon Lee1, Chang Deok Kim1 and Tae-Jin Yoon2
We obtained metastasized melanoma tissue from a primary acral lentiginous melanoma (ALM) patient and
established a melanoma cell line named primary culture of melanoma cell derived from lymph node (PML)-1.
PML-1 cells had a light brown color and decreased the expression of melanogenesis markers, including
tyrosinase (TYR), microphthalmia-associated transcription factor, and tyrosinase-related protein-1. To identify
genes differentially regulated in PML-1 melanoma cells, we performed DNA microarray and two-dimensional
matrix-assisted laser desorption ionization-time of flight mass spectrometry analyses. Among the candidate
genes identified, we chose NAD(P)H:quinone oxidoreductase-1 (NQO1) for further study. Reverse transcrip-
tion–PCR and western blot analyses showed that NQO1 was markedly decreased in PML-1 cells and in several
amelanotic melanoma cell lines. To investigate whether NQO1 affects the melanogenesis, we treated the
cultured normal human melanocytes (NHMC) and zebrafish with NQO1 inhibitors, ES936 and dicoumarol.
Interestingly, melanogenesis was significantly decreased by the addition of NQO1 inhibitors in both NHMC and
zebrafish models. In contrast, overexpression of NQO1 using a recombinant adenovirus clearly induced
melanogenesis, concomitantly with an increase of TYR protein level. These results suggest that NQO1 is a
positive regulator of the pigmentation process.
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INTRODUCTION
Melanocytes are specialized cells that produce melanin
pigments, thereby contributing to the appearance of skin
color. Melanins in the skin provide a primary defense system
against noxious environmental insults, including UV radia-
tion and visible light (Costin and Hearing, 2007). Melanins
are a complex group of heterogeneous biopolymers, which
can be classified into black/brown eumelanins and
red/yellow pheomelanins. Melanins are synthesized from
tyrosine through a well-characterized biochemical pathway in
which tyrosinase (TYR) acts as the rate-limiting enzyme (Land
et al., 2004; Wang and Hebert, 2006). Although the bio-
chemical pathway involved in melanin synthesis has been
well established, many of the factors regulating the pigmen-
tation process remain to be elucidated.
Melanoma is a type of skin cancer that originates from
melanocytes. The incidence of melanoma is relatively lower
than other types of skin cancers; however, it accounts for 80%
of the deaths from all skin cancers (Miller and Mihm, 2006).
Acral lentiginous melanoma (ALM) is one type of malignant
melanoma that is prevalent in Asian and African compared
with Caucasian populations (Phan et al., 2006). In this study,
we established a melanoma cell line from the metastatic
lymphoid tissue of a primary ALM patient, and named it PML-1
(primary culture of melanoma cell derived from lymph node).
Interestingly, PML-1 cells had a light brown color, whereas
normal melanocytes cultured from the same patient had an
intense black color. We thought that PML-1 cells would be a
good model for studying the regulation of pigmentation and
attempted to identify differentially expressed genes using
oligonucleotide microarrays, two–dimensional (2D) gel elec-
trophoresis, and matrix-assisted laser desorption ionization-
time of flight mass spectrometry (MALDI-TOFMS). Among the
several candidate genes identified, we chose NAD(P)H:qui-
none oxidoreductase-1 (NQO1) for further study, as it was
remarkably decreased in PML-1 cells.
NQO1 (EC 1.6.5.2) is a ubiquitous flavoenzyme that catalyzes
the two-electron reduction of quinones to hydroquinones using
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NAD(P)H as an electron donor (IUBMB page: http://
www.chem.qmul.ac.uk/iubmb/enzyme/EC1/6/5/2.html; Lind
et al., 1990; Riley and Workman, 1992; Asher et al., 2006).
NQO1 provides cells with multiple layers of protection
against oxidative stress, such as the direct detoxification of
highly reactive quinones, the maintenance of lipid-soluble
antioxidants in reduced forms, and stabilization of the tumor
suppressor p53 (Nioi and Hayes, 2004). In addition, a recent
study showed that the nuclear factor erythroid 2-related
factor 2 pathway and downstream NQO1 are involved in
the adaptation of skin keratinocytes and melanocytes
to environmental stress (Marrot et al., 2008). Although its
protective role has been well recognized, the impact of
NQO1 on melanogenesis has not been studied earlier.
Interestingly, evidence indicates that oxidative stress and
H2O2 are major players in the regulation of melano-
genesis in melanocytes, whereas NQO1 is an important
enzymatic antioxidant (Schallreuter et al., 2008; Wood
and Schallreuter, 2008). We speculate that NQO1 may
have an impact on pigmentation, and show for the first time
that NQO1 affects melanogenesis positively through the
regulation of TYR.
RESULTS
Establishment of the PML-1 melanoma cell line
We obtained metastasized melanoma tissue from a lymph
node in the right inguinal area of a Korean ALM patient
(Supplementary Figure 1), and then established the melano-
ma cell line named PML-1. PML-1 melanoma cells showed
quite a different morphology compared with normal human
melanocytes (NHMC) cultured from the same patient and
from a melanotic melanoma cell line MNT-1; i.e., enlarged
cell bodies and multiple dendrites (Figure 1a). Although
PML-1 cells were established from metastasized melanoma
tissue, they showed a remarkably slow rate of cell growth,
with an estimated doubling time of more than 3 weeks
(data not shown). The expression of tumor suppressors and
cell cycle regulators, including retinoblastoma, p53, p21,
and cyclin D1, was significantly reduced in PML-1 cells
(Figure 1b). Interestingly, PML-1 cells had a light brown color,
whereas NHMC and MNT-1 cells had intense black colors.
Thus, we next examined the protein levels of various
pigmentation markers, including microphthalmia-associated
transcription factor (MITF), TYR, tyrosinase-related protein-1
(TYRP1), and dopachrome tautomerase (DCT/TRP2). Protein
levels of MITF, TYR, and TYRP1 were markedly decreased in
PML-1 cells, whereas the DCT level was not changed (Figure
1c). These results indicate that the pigment-producing potential
is significantly reduced in PML-1 cells, and is at least part of the
reason why PML-1 cells have a light brown color.
Identification of differentially expressed genes in PML-1 cells
To identify genes differentially expressed in PML-1 cells,
we performed oligonucleotide microarray, 2D gel electro-
phoresis, and MALDI-TOFMS analyses. We obtained 604
differentially expressed genes by oligonucleotide microarray
(Supplementary Table 1) and 36 candidate proteins by
MALDI-TOFMS (Supplementary Table 2). Comparing the
results obtained by those two analytical methodologies, we
identified nine candidate genes whose expression was
markedly increased and/or decreased in PML-1 cells (Figure
2a and b). We chose the downregulated gene NQO1 for
further study, reasoning that the reduced expression of
pigmentation-related proteins such as MITF, TYR, and TYRP1
could result from the downregulation of melanogenic
regulators. To confirm the MALDI-TOFMS data (Figure 3a),
we first examined the expression level of NQO1 using
reverse transcription (RT)–PCR and western blot analyses,
which confirmed that the mRNA and protein levels for
NQO1 (isoform 1) were markedly decreased in PML-1 cells
(Figure 3b and c). As 3 splicing variants exist for the NQO1
transcript (Jaiswal et al., 1988; Gasdaska et al., 1995), we
also examined the transcript levels for the other NQO1
isoforms (2 and 3) using RT–PCR. The results showed that
NQO1 isoforms 2 and 3 were also decreased, suggesting that
NQO1 expression is regulated at the transcriptional level in
PML-1 cells (Figure 3b). Immunohistochemical analysis
revealed that the expression of NQO1 was not obvious in
the metastatic tissue of the ALM patient, whereas its
expression was easily detectable in the epidermis of a normal
skin region (Figure 3d).
Impact of NQO1 on pigmentation
On the basis of expression data, we hypothesized that
NQO1 may affect the pigmentation process directly and/or
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Figure 1. Characteristics of the PML-1 melanoma cells. (a) Morphology of
PML-1 melanoma cells derived from the metastatic lymphoid tissue of a
primary acral lentiginous melanoma (ALM) patient. Compared with normal
human melanocytes (NHMC) derived from the same patient and melanotic
MNT-1 melanoma cells, PML-1 cells show enlarged cell bodies and multiple
dendrites. (b) Western blot analysis of cell cycle-related genes in PML-1 cells.
(c) Western blot analysis of pigmentation markers; MITF, microphthalmia-
associated transcription factor; TYR, tyrosinase; TYRP1, tyrosinase-related
protein-1; DCT, dopachrome tautomerase. Actin was included as a loading
control. Scale bar¼ 25mm.
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Figure 2. Identification of differentially expressed genes in PML-1 melanoma cells. (a) List of differentially expressed genes, which were selected by comparison
of the results between the oligonucleotide microarray and the two-dimensional (2D) MALDI-TOFMS. Microarray analysis was performed with Cy5- and
Cy3-labeled probes, and then fluorescence intensity was assigned as the gene expression value (GEV) for determination of the relative gene expression level.
The results are shown as the mean values ±SD of duplicate measurements. (b) Expression of candidate genes in 2D PAGE and reverse transcription–PCR
analysis.
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Figure 3. Expression of NAD(P)H:quinone oxidoreductase-1 (NQO1) in PML-1 melanoma cells. (a) Two-dimensional gel analysis for comparison of protein
levels between normal human melanocytes (NHMC) (PML-N) and PML-1 cells. After MALDI-TOFMS analysis, NAD(P)H:quinone oxidoreductase-1 (NQO1)
was selected as a differentially expressed protein in PML-1 cells (red circle). Right panels show magnified images of the boxes in the left panels. PML-N,
normal melanocytes isolated from the acral lentiginous melanoma (ALM) patient; PML-1, melanoma cells established from the metastatic lymphoid tissue
of the same patient. (b) mRNA levels of NQO1 isoforms were determined by reverse transcription–PCR. Cyclophilin was included as a loading control.
(c) Protein level of NQO1 determined by western blot. Actin was used as a loading control. (d) Immunohistochemistry. The normal skin specimen and the
metastatic lymph node were obtained from the ALM patient, and then were fixed and paraffin-embedded. Sections were stained with the anti-NQO1 antibody.
Right panels show the DAPI staining. Scale bar¼10 mm.
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indirectly. We first examined the protein level of NQO1 in
various melanoma cell lines that showed different melano-
genic potentials. NHMC and MNT-1 cells were highly
melanogenic and produced melanin of black color, PML-1,
and SK-MEL-3 melanoma cells produced melanin of brown
color, whereas SK-MEL-2, SK-MEL-5, SK-MEL-24, SK-MEL-
28, and G361 cells were amelanotic (Figure 4a, pellet).
Interestingly, the melanogenic potential of various, if not all,
melanoma cell lines seemed to correspond with the NQO1
level (Figure 4a). Total cellular NQO1 activities matched
well with the protein levels in melanoma cell lines (Figure
4b). These results suggest that NQO1 may exert its role as a
positive regulator of melanogenesis. Thus, we next investi-
gated the effect of NQO1 inhibitors on pigmentation using an
in vitro cell culture system and an in vivo zebrafish model
(Choi et al., 2007). We used two NQO1 inhibitors in this
study. The first one was ES936 (5-methoxy-1,2-dimethyl-3-
[(4-nitrophenoxy)methyl]indole-4,7-dione), which is a
mechanism-based inhibitor with a Ki of 450 nM. The inhibi-
tion of NQO1 by ES936 is NADH-dependent and involves
the generation of reactive iminium species that alkylate a
Y residue of NQO1 (Winski et al., 2001; Dehn et al., 2003).
The second NQO1 inhibitor used was dicoumarol [3,30-
methylenebis(4-hydroxycoumarin)], which is the most potent
competitive known inhibitor of NQO1 with a Ki of 1–10 nM.
Dicoumarol competes with NAD(P)H for binding with
NQO1 and prevents the electron transfer to FAD (Cullen
et al., 2003). Treatment of NHMC with ES936 led to a
decrease in expression of melanogenic proteins such as MITF,
TYR, and TYRP1 in a dose-dependent manner (Figure 5a).
The inhibition of NQO1 by dicoumarol elicited similar
results, regardless of additional supplements to the growth
medium such as PMA or endothelin-1 (Figure 5b). Interest-
ingly, those two NQO1 inhibitors did not significantly affect
the DCT level, which was constant in PML-1 cells compared
with NHMC and MNT-1 cells (Figure 1c). These results
suggest that NQO1 may be an important regulator of melanin
production. In the zebrafish model, treatment with NQO1
inhibitors reduced the pigmentation dramatically, although
severe side effects were observed in the dicoumarol-treated
zebrafish embryos (Figure 5c).
The human NQO1 gene comprises six exons and five
introns, and produces three transcript variants by alternative
splicing (Figure 6a). In NHMC and in melanoma cells, all
three isoforms of NQO1 transcripts were identified (Figure
3b). To further investigate the effects of NQO1 on pigmenta-
tion, we generated recombinant adenoviruses expressing
NQO1 isoforms. After transduction into PML-1 cells, over-
expressed NQO1 isoforms were detected by western blot
analysis (Figure 6c). Overexpression of NQO1 isoforms did
not influence cell morphology (Figure 6b). Interestingly
however, secretion of melanin was significantly increased
by NQO1 isoform 1, but not by isoforms 2 or 3 (data not
shown). We speculated that NQO1 may enhance the
melanogenic potential in PML-1 cells, and then examined
the protein levels for MITF, TYR, and TYRP1. As shown in
Figure 6c, overexpression of NQO1 isoform 1 increased the
TYR protein level, whereas the levels of MITF and TYRP1
were slightly decreased. Again, no effect was noted in
response to NQO1 isoforms 2 or 3, suggesting that NQO1
isoform 1 is the one involved in the regulation of pigmenta-
tion. When NQO1 isoform 1 was overexpressed in PML-1
cells, the TYR enzymatic activity was also increased in a
dose-dependent manner (Figure 6d), which supports the
notion that NQO1 is an authentic regulator of pigmentation.
To further confirm the role of NQO1, we transduced NHMC
and amelanotic SK-Mel-2 melanoma cells with an adenovirus
expressing NQO1 isoform 1, which showed that over-
expression of NQO1 also led to an increase of TYR protein
level in both types of cells (Figure 6e). To investigate whether
NQO1 regulates TYR at the transcriptional level, we
performed RT–PCR analysis. After the adenovirus-driven
expression of NQO1 in PML-1 cells, the mRNA levels for
MITF, TYR, TYRP1, and DCT were not changed significantly
(Figure 6f). These results suggest that NQO1 may affect the
stability of TYR rather than the expression of its gene.
DISCUSSION
Although many genes involved in the regulation of pigmenta-
tion have been discovered, they are not sufficient to under-
stand the sophisticated molecular mechanisms underlying
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Figure 4. Expression and activity of NAD(P)H:quinone oxidoreductase-1
(NQO1) in melanoma cell lines. (a) Upper panels show the pellet color of
various melanoma cells cultured in vitro. Protein levels of tyrosinase (TYR)
and NAD(P)H:quinone oxidoreductase-1 (NQO1) were determined by
western blot; actin is included as a loading control. Normal human
melanocytes (NHMC) and MNT-1 cells show an intense black color; PML-1
and SK-MEL-3 melanoma cells show a yellow-brown color; SK-MEL-2, SK-
MEL-5, SK-MEL-24, SK-MEL-28, and G361 cells were amelanotic. (b) NQO1
activity in various melanoma cells cultured in vitro. Cell extracts were
incubated with reaction mixture, and then absorbances at 600 nm were
chased for 60 seconds. Enzyme activity is represented by the change of
absorbance. Data are averages and SEM of triplicate measurements.
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this process. In this study, we identified a previously
unidentified melanogenic regulator, NQO1, using oligonu-
cleotide microarray and 2D MALDI-TOFMS methods. The
results highlight the previously unidentified role of NQO1 in
melanogenesis. Specifically, we found that the melanogenic
potential is relatively well matched with NQO1 levels in
various melanoma cell lines, that the inhibition of NQO1
activity decreases melanogenesis, and that overexpression of
NQO1 enhances pigmentation through an increase of TYR.
NQO1 is a flavoenzyme that exerts its role in the cellular
defense mechanism against oxidative stress. NQO1 knockout
mice are more susceptible to oxidative stress, and show a
higher frequency of skin tumor development when carcino-
gens such as benzo(a)pyrene and 7,12-dimethylbenz(a)-
anthracene are applied topically (Long et al., 2000, 2001).
Furthermore, individuals with a lack of NQO1 owing to a
genetic polymorphism show an increased susceptibility to
certain cancers (Ross et al., 2000). In this study, we showed
that NQO1 protein level and enzymatic activity are reduced
in many melanoma cell lines, including PML-1, which was
derived from the metastatic lymphoid tissue of a primary
ALM patient. Considering the physiological function of
NQO1 to detoxify potentially mutagenic compounds, it
could be suggested that decreased NQO1 activity predis-
poses melanocytes to a cancerous stage. A correlation
between NQO1 and melanoma development will be an
interesting further study.
In this study, we showed that the inhibition of NQO1
activity decreases melanogenesis, whereas the overexpres-
sion of NQO1 enhances pigmentation, likely through the
regulation of the TYR level. Although the precise mech-
anism remains to be elucidated, our data suggest that
NQO1 may affect the stability of TYR rather than its
gene expression, because the overexpression of NQO1 did
not increase the mRNA level for TYR in PML-1 cells. As
it has been shown that NQO1 interacts with a broad
range of substrates including p53 and ornithine decarbox-
ylase (Anwar et al., 2003; Asher et al., 2005), we hypo-
thesized that TYR could be a direct substrate for NQO1,
thereby acquiring the more stable configuration. However, in
a preliminary immunoprecipitation assay, we were unable to
show a direct interaction between NQO1 and TYR (data
not shown), which suggests that the stabilization of TYR
by NQO1 is mediated through another regulatory mechan-
ism. One possible candidate is the proteasomal degradation
machinery. Evidence shows that NQO1 inhibits the ubiqui-
tin-independent degradation of ornithine decarboxylase
by the 20S proteasome (Asher et al., 2005). Furthermore,
NQO1 protects the tumor suppressor p53 against 20S
proteasomal degradation, leading to the stabilization and
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Figure 5. Effect of NAD(P)H:quinone oxidoreductase-1 (NQO1) inhibitors on pigmentation. Normal human melanocytes (NHMC) were treated with the
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activation of p53 (Gong et al., 2007). A similar pheno-
menon has also been shown for the tumor suppressor p33
(ING1b) (Garate et al., 2008). Together, these results suggest
that NQO1 may inhibit the activity of the 20S proteasome,
thereby stabilizing a broad range of target proteins that are
destined for proteasomal degradation. Elucidation of whether
NQO1 regulates the TYR level in a similar manner will be an
interesting further study.
In summary, we identified a previously unidentified
melanogenic regulator, NQO1, and showed its positive regu-
latory role in melanogenesis. Our results provide a previously
unidentified insight on which to base further investigations
of the molecular events that occur during the process of
pigmentation.
MATERIALS AND METHODS
Cell culture
Metastatic lymphoid and normal tissue of primary ALM patients and
normal foreskin samples were obtained under the written informed
consent of the donors, in accordance with the ethics committee
approval process of the Gyeongsang National University Hospital.
The study was conducted according to the Declaration of Helsinki
Principles. Skin samples were briefly sterilized in 70% ethanol,
minced, and then treated with dispase overnight at 4 1C. The
epidermis was separated and placed in a solution containing 0.05%
trypsin and 0.02% EDTA (Gibco BRL, Rockville, MD) for 30minutes
at 37 1C. After vigorous pipetting, the cells were pelleted and
resuspended in a growth medium composed of Medium 154
and human melanocyte growth supplement (Cascade Biologics,
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Figure 6. Impact of NAD(P)H:quinone oxidoreductase-1 (NQO1) on pigmentation. (a) Gene structure of human NAD(P)H:quinone oxidoreductase-1
(NQO1) and splicing variants. The NQO1 isoform 1 has all exons in its mRNA transcript, whereas isoform 2 lacks exon 5 and isoform 3 lacks exon 4 in their
mRNA transcripts. (b) Morphology of primary culture of melanoma cell derived from lymph node (PML-1) cells after transduction of adenoviruses expressing
NQO1 isoforms. Cells were incubated with the recombinant adenoviruses (10MOI, multiplicity of infection) for 18 hours, and then were replenished with fresh
medium and incubated for 3 days. Overexpression of NQO1 isoforms did not affect cell morphology significantly. (c) PML-1 cells were transduced with
adenoviruses (10MOI), and then protein levels for microphthalmia-associated transcription factor (MITF), tyrosinase (TYR), tyrosinase-related protein-1 (TYRP1),
and NQO1 were determined by Western blot. Arrow indicates the NQO1 isoform 1. Arrowhead indicates the NQO1 isoforms 2 and 3. Actin was used
as a loading control. (d) Effect of NQO1 (isoform 1) on TYR activity in PML-1 cells. After adenoviral transduction at the indicated MOI, cell extracts were
prepared. For measurement of TYR activity, 250mg total protein was incubated with L-DOPA (0.5mM) (upper panel), and then quantified using a spectrometer
(middle panel). The results are shown as percentage of control. All experiments were repeated three times. The lower panel shows protein levels for TYR
and NQO1 after adenoviral transduction. (e) Effect of NQO1 (isoform 1) on tyrosinase activity in normal human melanocytes (NHMC) and in amelanotic
melanoma SK-Mel-2 cells. Cells were transduced with 10MOI adenovirus expressing NQO1, and then protein levels for TYR and NQO1 were determined
by Western blot. (f) Effect of NQO1 (isoform 1) on the transcription of pigmentation markers in PML-1 cells. Cells were transduced with 10MOI adenovirus,
and then mRNA levels for MITF, TYR, TYRP1, DCT, and NQO-1 were determined by reverse transcription–PCR. Cyclophilin was used as a loading control.
Scale bar¼ 25 mm.
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Portland, OR). During the primary culture of human melanocytes,
200mgml1 G418 (geneticin sulfate, Duchefa, Haarlem, The
Netherlands) was added to the growth medium to suppress the
proliferation of fibroblasts. PML-1 melanoma cells were established
in a similar manner. Other melanoma cells were maintained in
DMEM supplemented with 10–20% fetal bovine serum (Gibco BRL).
Oligonucleotide microarray and 2D MALDI-TOFMS
To identify genes differentially expressed in PML-1 cells, we used two
different methodologies: oligonucleotide microarray at the mRNA
level and 2D MALDI-TOFMS at the protein level. Comparisons were
performed between melanoma cells (PML-1) and normal melanocytes
(PML-N), both of which were established from the same patient.
For oligonucleotide microarray, total RNAs were isolated using a
Tri reagent (Sigma, St Louis, MO). Fluorescent-labeled probes were
prepared and applied to the 27 K human oligonucleotide microarray
slides (GenomicTree, Daejeon, Korea) as reported earlier (Seo et al.,
2005). Microarray slides were analyzed using the GenePix Pro 4.0
software (Axon Instruments, Union City, CA) and GeneSpring 7.2
software (Agilent Technologies, Redwood City, CA). Oligonucleo-
tide microarray was repeated twice with the total RNAs isolated from
different batches of culture.
For 2D MALDI-TOFMS, cellular proteins were solubilized in urea
buffer (Yang et al., 2006). Two hundred mg cellular proteins were first
separated using an immobiline DryStrip (pH 3–10, GE Healthcare
Bio-Sciences, Piscataway, NJ), and then SDS–PAGE was performed
on 8–16% gradient gels. After SDS–PAGE, gels were stained with
silver nitrate and scanned using the Proteome Weaver software
(Definiens, Munchen, Germany). Selected spots were in-gel digested
by trypsin and analyzed by MALDI-TOFMS (Voyager-DE STR,
Applied Biosystems, Foster City, CA).
Production of an adenovirus expressing NQO1 isoforms
A replication-incompetent adenovirus was created using the Vira-
power adenovirus expression system (Invitrogen, Carlsbad, CA) as
reported earlier (Yoon et al., 2008). Briefly, the full-length NQO1
and its isoforms were obtained using the primers 50-ATGGTCG
GCAGAAGAGCACTGA and 50-CAGATCAAAGCTAGAAAATGA,
subcloned into the pENT/CMV-GFP entry vector. Site-specific
recombination between the entry vector and the adenoviral
destination vector was achieved by LR clonase II (Invitrogen). The
resulting adenoviral expression vector was transfected into 293A
cells using Lipofectamine 2000 (Invitrogen). Cells were grown until
80% cytopathic effect was seen, and then were harvested for
preparation of stock recombinant adenovirus. The adenovirus was
purified with cesium chloride according to the method reported
earlier (Tollefson et al., 2007).
Tyrosinase and NQO1 activity
TYR activity was determined as described earlier with a slight
modification (Choi et al., 2007). Briefly, cells were sonicated in protein
extraction solution, after which lysates were clarified by centrifugation.
After quantification, 250mg total proteins in 100ml lysis buffer were
transferred into 96-well plates, and 100ml of 1mM L-DOPA was
added. After incubation for 60minutes at 37 1C, absorbances were
measured at 475nm. TYR activity is expressed as a percentage of
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the control. All experiments were performed at least three times with
similar results.
For measurement of NQO1 activity, cells were homogenized in a
solution containing 0.25M sucrose, 50mM Tris-Cl, pH 7.4, and
proteinase inhibitors. Lysates were clarified by centrifugation at
50,000 r.p.m. for 1 hour, incubated in the reaction mixture (25mM
Tris-Cl, pH 7.4, 200mM NADH, 200mgml1 BSA, and 50 mM DCPIP),
and absorbances were measured at 600 nm.
Western blot analysis
Cellular proteins were separated by SDS–PAGE, transferred onto
nitrocellulose membranes, and then incubated with appropriate
antibodies overnight at 4 1C with gentle agitation. Blots were then
incubated with peroxidase-conjugated secondary antibodies for 30min-
utes at room temperature, and visualized by enhanced chemilumines-
cence (Intron, Daejeon, Korea). The following primary antibodies were
used in this study: p53, p21, cyclin D1, phosphor-retinoblastoma, total-
retinoblastoma, MITF, and NQO1 (Santa Cruz Biotechnologies, Santa
Cruz, CA), TYR, TYRP1, and DCT (kindly provided by Dr Vincent J.
Hearing, NIH, Bethesda, MD), and actin (Sigma).
Zebrafish test
Adult zebrafish were kept in a 5 l acrylic tank at 28.5 1C with a
14/10 hours light/dark cycle. Embryos were obtained from natural
spawning that was induced in the morning by turning on the light.
Collection of embryos was completed within 30minutes. Synchro-
nized embryos were placed in 35-mm culture dishes containing a
2ml embryo medium. Test compounds were dissolved in 0.1%
DMSO, and then added to the embryo medium from 9hours
postfertilization (hpf) to 30 hpf. To observe the effect on pigmenta-
tion, embryos were dechorionated by forceps, anesthetized in
tricaine methanesulfonate solution (Sigma), mounted in 3% methyl
cellulose on a depression slide (Aquatic Eco-Systems, Apopka, FL),
and photographed under the stereomicroscope MZ16 (Leica Micro-
systems, Ernst-Leitz-Strasse, Germany).
Statistical analysis
Data were evaluated statistically using Student’s t-test. Statistical
significance was set at Po0.05.
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